Enfusion, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2021 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Enfusion, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q3 2024.
- Enfusion, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $904K, a 146% increase year-over-year.
- Enfusion, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $2.47M, a 80.3% increase year-over-year.
- Enfusion, Inc. annual Income Tax Expense (Benefit) for 2023 was $2.23M, a 108% increase from 2022.
- Enfusion, Inc. annual Income Tax Expense (Benefit) for 2022 was $1.07M, a 85.5% increase from 2021.
- Enfusion, Inc. annual Income Tax Expense (Benefit) for 2021 was $579K, a 33.7% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)